comparemela.com

Latest Breaking News On - Ronen tsimerman - Page 5 : comparemela.com

IceCure Medical to Report H1 2022 Results and Conduct Conference Call on August 15, 2022

/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.

United statesCentrastate medical centerNew jerseyKenneth tomkovichRonen tsimermanIsrael internationalPrnewswire icecure medical ltdDrug administrationRadiologists society of north americaCompany annual report on formCure medicalInterventional radiologistPrinceton radiologyBreast imagingRespiratory medicineAcademic radiology

IceCure Announces Regulatory Filing Submission for Approval of ProSense® in Canada for Indications Including Ablation of Benign and Malignant Breast Tumors

/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.

Ronen tsimermanEyal shamirSecurities exchange commissionPrnewswire icecure medical ltdDrug administrationCompany annual report on formCanadian cancer societyIcecure medical ltdHealth canadaCure medicalProsense systemPrivate securities litigation reform actRisk factorsAnnual reportIcecure medical

Former Itamar Medical CEO & President Gilad Glick Joins IceCure Medical as a Strategic Advisor for Global Go-To-Market Operations

/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.

Ronen tsimermanEyal shamirGilad glickItamar medical incPrnewswire icecure medical ltdCompany prosenseDrug administrationCompany annual report on formExchange commissionMedtech commercialization instituteBeta bionics incItamar medicalZoll medicalCure medicalMedtech commercializationBiosense webster

IceCure Medical, Shanghai Medtronic & Turing Medical Sign Distribution Agreement in Mainland China

/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.

Yu jingLin youjiaRonen tsimermanEyal shamirPrnewswire icecure medical ltdDrug administrationTuring medical technology coShanghai medtronic zhikang medical devices coCompany annual report on formNational medical products administrationIcecure shanghai medtech co ltdShanghai medtronicCure medicalShanghai medtronic zhikang medical devicesBeijing turing medical technologyShanghai medtronic vice president

IceCure Medical s ProSense® Cryoablation System Submitted for Regulatory Approval in Brazil

/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.

United statesRonen tsimermanEyal shamirCompany annual report on formBrazilian health regulatory agencyIcecure medical ltdWorld health organizationDrug administrationIcecure medicalCancer tomorrowLatin americaIsrael based icecure medicalPrivate securities litigation reform actRisk factorsAnnual report

vimarsana © 2020. All Rights Reserved.